4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0001171843-26-006349
Chief Accounting Officer bought 20,000 shares at $0.92 ($18,400)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lerner Neil Chief Accounting Officer | 2026-10-01 | Purchase | +20,000 | $0.92 | $18,400 | 420,000 | D |
| Open-market purchases · 20,000 sh · avg $0.92 · $18,400 | |||||||
Loading xslF345X06/ownership.xml…